Previous studies have adopted nomograms to establish prognostic models for NSLCL patients; however, those previous models did not include information related to EGFR mutation status.[8, 9, 25–28] Accurate prognostication for advanced NSCLC is important not only to select patients for treatments but also to inform patients accurately about their long-term prognosis. Here, EGFR is linked to non-small cell lung carcinoma.